Bliss GVS Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchanges that its trading window will be closed for insiders, designated persons, and their immediate relatives starting Tuesday, July 1, 2025. The closure will remain in effect until 48 hours after the company publicly announces its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine compliance requirement under SEBI's Insider Trading Regulations. The date of the board meeting to approve these quarterly results will be communicated separately.
No direct impact on shareholders — this is a standard regulatory filing. However, it signals that Q1 FY26 results are imminent, which could influence short-term stock movement once announced. Insiders are barred from trading during this period.